Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+42.4%
5Y CAGR+43.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+42.4%/yr
vs +18.3%/yr prior
5Y CAGR
+43.2%/yr
Consistent
Acceleration
+24.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $438.47M | +20.9% |
| 2024 | $362.53M | +57.7% |
| 2023 | $229.95M | +51.5% |
| 2022 | $151.76M | +33.7% |
| 2021 | $113.49M | +55.6% |
| 2020 | $72.94M | +23.5% |
| 2019 | $59.06M | -23.7% |
| 2018 | $77.39M | +20.8% |
| 2017 | $64.06M | +42.4% |
| 2016 | $44.99M | - |